Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lunetta

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALSEttore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
Journal of Clinical Medicine|April 26, 2025
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4)Irene Giovanna Aprile, Marco Germanotta, Alessio Fasano, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 10, 2012
Replication of association of CHRNA4 rare variants with sporadic amyotrophic lateral sclerosis: the Italian multicentre studyMario Sabatelli, Serena Lattante, Amelia Conte, et al.
International Journal of Molecular Sciences|May 27, 2026
Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated <i>SOD1</i>-ALS: A Real-World Multicentre Cohort StudyAndrea Giordano, Jessica Mandrioli, Federica Cerri, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 26, 2020
Focus on the heterogeneity of amyotrophic lateral sclerosisCaterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, et al.
Annals of Neurology|April 8, 2014
Physical activity and amyotrophic lateral sclerosis: a European population-based case-control studyElisabetta Pupillo, Paolo Messina, Giorgia Giussani, et al.
Molecular Neurodegeneration|August 11, 2021
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosisLaura Pasetto, Stefano Callegaro, Alessandro Corbelli, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 25, 2017
Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortiumElisabetta Pupillo, Marco Poloni, Elisa Bianchi, et al.
Journal of Neurology|May 5, 2023
Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patientsEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALSEttore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
Journal of Clinical Medicine|April 26, 2025
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4)Irene Giovanna Aprile, Marco Germanotta, Alessio Fasano, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 10, 2012
Replication of association of CHRNA4 rare variants with sporadic amyotrophic lateral sclerosis: the Italian multicentre studyMario Sabatelli, Serena Lattante, Amelia Conte, et al.
International Journal of Molecular Sciences|May 27, 2026
Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated <i>SOD1</i>-ALS: A Real-World Multicentre Cohort StudyAndrea Giordano, Jessica Mandrioli, Federica Cerri, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 26, 2020
Focus on the heterogeneity of amyotrophic lateral sclerosisCaterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, et al.
Annals of Neurology|April 8, 2014
Physical activity and amyotrophic lateral sclerosis: a European population-based case-control studyElisabetta Pupillo, Paolo Messina, Giorgia Giussani, et al.
Molecular Neurodegeneration|August 11, 2021
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosisLaura Pasetto, Stefano Callegaro, Alessandro Corbelli, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 25, 2017
Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortiumElisabetta Pupillo, Marco Poloni, Elisa Bianchi, et al.
Journal of Neurology|May 5, 2023
Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patientsEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Pageof 17